Health Care & Life Sciences » Pharmaceuticals | Myungmoon Pharmaceutical Co. Ltd.

Myungmoon Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Myungmoon Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DFA Emerging Markets Small Cap Series
169,441
0.69%
0
0.02%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
149,885
0.61%
-2
0%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
8,139
0.03%
8,139
0%
12/31/2017
DFA Emerging Markets Social Core Equity Portfolio
8,085
0.03%
0
0%
04/30/2018
5,968
0.02%
3,832
0.02%
04/30/2018
DFA World (ex-US) Core Equity Portfolio
4,773
0.02%
0
0%
04/30/2018
DFA TA World (ex-US) Core Equity Portfolio
4,773
0.02%
0
0%
04/30/2018
John Hancock II - Emerging Markets Fund
3,904
0.02%
0
0%
04/30/2018

About Myungmoon Pharmaceutical Co.

View Profile
Address
26 Jeyakgongdan 2-gil
Hwaseong GY 18622
Korea, Republic Of
Employees -
Website http://www.mmpharm.co.kr
Updated 07/08/2019
MyungMoon Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include ethical drugs (ETC), over-the-counter drugs (OTC) and indication drugs. The ethical drugs include anesthetic agent, analgesic agent, anti-epileptics, anti-depressants, anti-diabetics, anti-osteoporosis and others.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.